View in EDS PDF Full Text

Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.

Saved in:
Bibliographic Details
Title: Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.
Authors: Abraham M; Biokine Therapeutics Ltd, Ness Ziona, Israel., Wald H; Biokine Therapeutics Ltd, Ness Ziona, Israel., Vaizel-Ohayon D; Biokine Therapeutics Ltd, Ness Ziona, Israel., Grabovsky V; Biokine Therapeutics Ltd, Ness Ziona, Israel., Oren Z; Biokine Therapeutics Ltd, Ness Ziona, Israel., Karni A; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Weiss L; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel., Galun E; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel., Peled A; Biokine Therapeutics Ltd, Ness Ziona, Israel.; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel., Eizenberg O; Biokine Therapeutics Ltd, Ness Ziona, Israel.
Source: Frontiers in immunology [Front Immunol] 2017 Nov 23; Vol. 8, pp. 1432. Date of Electronic Publication: 2017 Nov 23 (Print Publication: 2017).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29218043
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Abraham+M%22">Abraham M</searchLink>; Biokine Therapeutics Ltd, Ness Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Wald+H%22">Wald H</searchLink>; Biokine Therapeutics Ltd, Ness Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Vaizel-Ohayon+D%22">Vaizel-Ohayon D</searchLink>; Biokine Therapeutics Ltd, Ness Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Grabovsky+V%22">Grabovsky V</searchLink>; Biokine Therapeutics Ltd, Ness Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Oren+Z%22">Oren Z</searchLink>; Biokine Therapeutics Ltd, Ness Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Karni+A%22">Karni A</searchLink>; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Weiss+L%22">Weiss L</searchLink>; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Galun+E%22">Galun E</searchLink>; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Peled+A%22">Peled A</searchLink>; Biokine Therapeutics Ltd, Ness Ziona, Israel.; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Eizenberg+O%22">Eizenberg O</searchLink>; Biokine Therapeutics Ltd, Ness Ziona, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2017 Nov 23; Vol. 8, pp. 1432. <i>Date of Electronic Publication: </i>2017 Nov 23 (<i>Print Publication: </i>2017).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-3224 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29218043
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2017.01432
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1432
    Titles:
      – TitleFull: Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Abraham M
      – PersonEntity:
          Name:
            NameFull: Wald H
      – PersonEntity:
          Name:
            NameFull: Vaizel-Ohayon D
      – PersonEntity:
          Name:
            NameFull: Grabovsky V
      – PersonEntity:
          Name:
            NameFull: Oren Z
      – PersonEntity:
          Name:
            NameFull: Karni A
      – PersonEntity:
          Name:
            NameFull: Weiss L
      – PersonEntity:
          Name:
            NameFull: Galun E
      – PersonEntity:
          Name:
            NameFull: Peled A
      – PersonEntity:
          Name:
            NameFull: Eizenberg O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 11
              Text: 2017 Nov 23
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-print
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 8
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1